Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5126]

Lutetium-177 PSMA scanning for prostate cancer

Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA

Lutetium-177 PSMA scanning for prostate cancer ( Dr Scott Tagawa - Weill Cornell Medicine, New York City, USA )

Highlights from ESMO 2019

Prof Josep Tabernero - ESMO President

Highlights from ESMO 2019 ( Prof Josep Tabernero - ESMO President )

SPICE: Analysis of enadenotucirev plus nivolumab in metastatic colorectal...

Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA

SPICE: Analysis of enadenotucirev plus nivolumab in metastatic colorectal cancer patients during the dose escalation phase ( Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA )

Pembrolizumab plus platinum-based chemotherapy for metastatic NSCLC

Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain

Pembrolizumab plus platinum-based chemotherapy for metastatic NSCLC ( Dr Luis Paz-Ares - Hospital Universitario Doce de Octubre, Madrid, Spain )

Association between tTMB and clinical outcomes with pembrolizumab alone in PD...

Prof Roy Herbst - Yale Cancer Center, New Haven, USA

Association between tTMB and clinical outcomes with pembrolizumab alone in PD-L1-positive advanced NSCLC in KEYNOTE-010 and -042 ( Prof Roy Herbst - Yale Cancer Center, New Haven, USA )

AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours

Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA

AMG 510: A novel molecule targeting KRAS G12C mutant solid tumours ( Prof Marwan Fakih - City of Hope National Medical Center, Duarte, USA )

MEDIOLA: Olaparib and durvalumab for germline BRCA-mutated metastatic breast...

Prof Susan Domchek - University of Pennsylvania, Pennsylvania, USA

MEDIOLA: Olaparib and durvalumab for germline BRCA-mutated metastatic breast cancer ( Prof Susan Domchek - University of Pennsylvania, Pennsylvania, USA )

Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative...

Dr Véronique Diéras - Centre Eugène Marquis, Rennes, France

Phase III study of veliparib with carboplatin and paclitaxel in HER2-negative advanced/metastatic gBRCA-associated breast cancer ( Dr Véronique Diéras - Centre Eugène Marquis, Rennes, France )

CUPISCO: Identifying carcinoma of unknown primary patients according to ESMO...

Prof Jeffrey S. Ross - Albany Medical Center, Albany, USA

CUPISCO: Identifying carcinoma of unknown primary patients according to ESMO guidelines ( Prof Jeffrey S. Ross - Albany Medical Center, Albany, USA )

CheckMate 459: Safety and efficacy of nivolumab versus sorafenib as a first...

Dr Thomas Yau - The University of Hong Kong, Hong Kong

CheckMate 459: Safety and efficacy of nivolumab versus sorafenib as a first-line treatment in advanced hepatocellular carcinoma ( Dr Thomas Yau - The University of Hong Kong, Hong Kong )

INVICTUS: Assessing the safety and efficacy of ripretinib in patients with...

Prof Margaret von Mehren - Fox Chase Cancer Center, Philadelphia, USA

INVICTUS: Assessing the safety and efficacy of ripretinib in patients with advanced gastrointestinal stromal tumours ( Prof Margaret von Mehren - Fox Chase Cancer Center, Philadelphia, USA )

Using PARP inhibitors to improve quality of life for patients with metastatic...

Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

Using PARP inhibitors to improve quality of life for patients with metastatic breast cancer ( Prof Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia )

More from ecancer